Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2016-05-13 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
独立董事独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on a board resolution regarding the termination of an investment project. It references compliance with regulatory guidelines and company governance rules. The content focuses on board meeting decisions and independent director opinions rather than financial results, audit, or shareholder voting outcomes. It is not a full annual report, audit report, or earnings release. It is also not a voting result announcement or a proxy solicitation. The document fits best under Board/Management Information (MANG) as it relates to board decisions and governance matters.
2016-05-13 Chinese
关于延期回复上海证券交易所问询函及继续停牌的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by the company 中源协和细胞基因工程股份有限公司 regarding the delay in responding to an inquiry letter from the Shanghai Stock Exchange and the continuation of trading suspension. It details the company's ongoing efforts to address regulatory inquiries, industry policy impacts, and risk management related to a non-public issuance and guarantee risks. The document is relatively short (1368 characters) and serves as a status update on regulatory communication and trading suspension rather than a financial report or detailed management discussion. It does not contain financial statements, audit information, or detailed report content. Therefore, it fits best as a Regulatory Filing (RNS), which is a general regulatory announcement and compliance document category for filings that do not fit other specific categories.
2016-05-12 Chinese
关于副总经理辞职的公告
Board/Management Information Classification · 100% confidence The document is a short announcement regarding the resignation of the company's Vice General Manager. It includes the date of resignation and expresses gratitude for the individual's contributions. There is no financial data, no mention of reports, no voting results, no legal proceedings, or other detailed corporate filings. This fits the category of Board/Management Information (MANG), which covers announcements of changes in senior management.
2016-05-10 Chinese
关于对外投资事项变更的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by the company 中源协和细胞基因工程股份有限公司 regarding a change in an external investment matter. It details the investment amount, the parties involved, the investment agreement, the purpose, and the risks associated with the investment. The document is an announcement of a corporate action related to investment and does not contain financial statements, audit information, or detailed financial results. It is not a report like an Annual Report or Interim Report, nor is it a regulatory certification or voting result. The document is a formal announcement of a change in investment plans, which fits best under the category of Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2016-05-09 Chinese
关于广州拓普基因科技有限公司投资参股公司下属公司广东顺德基因科技有限公司的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding an investment transaction where Guangzhou Top Gene Technology Co., Ltd. invests in a subsidiary of Zhongyuan Xiehe Cell Gene Engineering Co., Ltd. It details the transaction overview, parties involved, contract terms, and the impact on the company. There is no indication that this is a financial report, audit, earnings release, or regulatory filing. The content focuses on a capital investment and shareholding change in a subsidiary, which fits the category of Capital/Financing Update (CAP). The document length is 2586 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the classification is Capital/Financing Update (CAP) with high confidence.
2016-05-09 Chinese
第八届董事会第五十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of Zhongyuan Xiehe Cell Gene Engineering Co., Ltd. It details the voting results on various investment-related proposals and references other announcements for further details. The document is short (877 characters) and focuses on board decisions rather than financial data or report content. It does not contain financial statements or detailed management discussion. The key elements are the board meeting resolutions and voting results on investment matters, which aligns with announcements related to board or management information. Therefore, the document fits best under the category of Board/Management Information (MANG).
2016-05-09 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.